新闻

Sichenzia Ross Ference Carmel LLP 代表 Verb Technology Company, Inc. 根据 A 条例进行 660 万美元普通股发行

By Sichenzia Ross Ference LLP | 26 3 月, 2024

Verb Technology Company, Inc.

$6,600,000

Regulation A Offering

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 EF Hutton 参与 AppTech Payments Corp. 200 万美元的公开发行。

By Sichenzia Ross Ference LLP | 26 3 月, 2024

AppTech Payments Corp.

$2,000,000

Public Offering

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 Beyond Air 进行 1600 万美元的注册直接发行

By Sichenzia Ross Ference LLP | 25 3 月, 2024

Beyond Air, Inc.

$16,000,000

Registered Direct Offering

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 ShiftPixy, Inc. 公开发行 500 万美元

By Sichenzia Ross Ference LLP | 25 3 月, 2024

ShiftPixy, Inc.

$5,000,000

Public Offering

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 Aegis Capital Corp. 参与 C3is Inc. 600 万美元的公开发行。

By Sichenzia Ross Ference LLP | 20 3 月, 2024

C3is Inc.

$6,000,000

Common Stock

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 Worksport Ltd. 公开发行 280 万美元

By Sichenzia Ross Ference LLP | 19 3 月, 2024

Worksport Ltd.

$2,800,000

Common Stock

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 Nature’s Miracle, Inc. 与 Lakeshore Acquisition II Corp. 进行业务合并。

By Sichenzia Ross Ference LLP | 16 3 月, 2024

Nature’s Miracle, Inc.

Business Combination

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 WallachBeth Capital 进行 250 万美元的公开发行

By Sichenzia Ross Ference LLP | 11 3 月, 2024

bioAffinity Technologies

$2,500,000

Common Stock

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 ThinkEquity LLC 和 Laidlaw & Company (UK) Ltd. 进行 210 万美元承销公开发行

By Sichenzia Ross Ference LLP | 6 3 月, 2024

Oragenics Inc.

$2,100,000

Common Stock

March 2024

Read More

Sichenzia Ross Ference Carmel LLP 代表 EF Hutton LLC 承销 NRx Pharmaceuticals 的 150 万美元公开发行

By Sichenzia Ross Ference LLP | 28 2 月, 2024

NRx Pharmaceuticals

$1,500,000

Common Stock and Warrants

February 2024

Read More